4//SEC Filing
ROSS GEORGE K 4
Accession 0001104659-24-000290
CIK 0000786947other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 3:23 PM ET
Size
10.6 KB
Accession
0001104659-24-000290
Insider Transaction Report
Form 4
ROSS GEORGE K
Director
Transactions
- Award
Restricted Stock Units (2021 Plan)
2024-01-02−50,000→ 50,000 total→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2024-01-02+50,000→ 495,503 total - Exercise/Conversion
Restricted Stock Units (2021 Plan)
2024-01-02−50,000→ 0 total→ Common Stock (50,000 underlying)
Footnotes (7)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vested on the last day of each of March, June, September and December 2023. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]50,000 Restricted Stock Units were granted on January 3, 2024. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2024, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2025, or earlier upon a change of control.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001068724
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 3:23 PM ET
- Size
- 10.6 KB